R01 HL087061/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2009	2
2010	2
2011	6
2012	2
2013	1
2014	3
2015	3
2018	2
2019	1
2023	1
2024	0

1

Mechanisms of Lymphatic Endothelial Cell Junction Transformations.

Zhong J, Shelton EL, Kirabo A, Kon V. Zhong J, et al. Circ Res. 2023 Aug 4;133(4):350-352. doi: 10.1161/CIRCRESAHA.123.323210. Epub 2023 Aug 3. Circ Res. 2023. PMID: 37535754 No abstract available.

2

Kidney as modulator and target of "good/bad" HDL.

Zhong J, Yang H, Kon V. Zhong J, et al. Pediatr Nephrol. 2019 Oct;34(10):1683-1695. doi: 10.1007/s00467-018-4104-2. Epub 2018 Oct 5. Pediatr Nephrol. 2019. PMID: 30291429 Free PMC article. Review.

3

Chronic kidney disease induced dysfunction of high density lipoprotein.

Yamamoto S, Kon V. Yamamoto S, et al. Clin Exp Nephrol. 2014 Apr;18(2):251-4. doi: 10.1007/s10157-013-0857-x. Epub 2013 Sep 10. Clin Exp Nephrol. 2014. PMID: 24018401 Free PMC article. Review.

4

Scope and mechanisms of obesity-related renal disease.

Hunley TE, Ma LJ, Kon V. Hunley TE, et al. Curr Opin Nephrol Hypertens. 2010 May;19(3):227-34. doi: 10.1097/MNH.0b013e3283374c09. Curr Opin Nephrol Hypertens. 2010. PMID: 20134323 Free PMC article. Review.

5

Atherosclerosis in chronic kidney disease: the role of macrophages.

Kon V, Linton MF, Fazio S. Kon V, et al. Nat Rev Nephrol. 2011 Jan;7(1):45-54. doi: 10.1038/nrneph.2010.157. Epub 2010 Nov 23. Nat Rev Nephrol. 2011. PMID: 21102540 Free PMC article. Review.

6

Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Kon V, Yang H, Fazio S. Kon V, et al. Arch Med Res. 2015 Jul;46(5):379-91. doi: 10.1016/j.arcmed.2015.05.009. Epub 2015 May 23. Arch Med Res. 2015. PMID: 26009251 Free PMC article. Review.

7

Dysfunctional high-density lipoproteins in children with chronic kidney disease.

Kaseda R, Jabs K, Hunley TE, Jones D, Bian A, Allen RM, Vickers KC, Yancey PG, Linton MF, Fazio S, Kon V. Kaseda R, et al. Metabolism. 2015 Feb;64(2):263-73. doi: 10.1016/j.metabol.2014.10.020. Epub 2014 Oct 25. Metabolism. 2015. PMID: 25467845 Free PMC article.

8

Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity.

Ma LJ, Corsa BA, Zhou J, Yang H, Li H, Tang YW, Babaev VR, Major AS, Linton MF, Fazio S, Hunley TE, Kon V, Fogo AB. Ma LJ, et al. Am J Physiol Renal Physiol. 2011 May;300(5):F1203-13. doi: 10.1152/ajprenal.00468.2010. Epub 2011 Mar 2. Am J Physiol Renal Physiol. 2011. PMID: 21367915 Free PMC article.

9

Protective effects of PPARγ agonist in acute nephrotic syndrome.

Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB. Zuo Y, et al. Nephrol Dial Transplant. 2012 Jan;27(1):174-81. doi: 10.1093/ndt/gfr240. Epub 2011 May 12. Nephrol Dial Transplant. 2012. PMID: 21565943 Free PMC article.

10

Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Kaseda R, Tsuchida Y, Gamboa JL, Zhong J, Zhang L, Yang H, Dikalova A, Bian A, Davies S, Fogo AF, Linton MF, Brown NJ, Ikizler TA, Kon V. Kaseda R, et al. Nutr Metab Cardiovasc Dis. 2018 Jun;28(6):582-591. doi: 10.1016/j.numecd.2018.02.020. Epub 2018 Mar 8. Nutr Metab Cardiovasc Dis. 2018. PMID: 29691148 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year